OtherPredictive factors of benefit from iodine-125 brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis

Add time:08/13/2019    Source:sciencedirect.com

PurposeThe aims of this study were to evaluate treatment responses and predictive factors for overall survival (OS) in hepatocellular carcinoma (HCC) patients with portal vein tumor thrombosis (PVTT) treated with iodine-125 (125I) brachytherapy.

We also recommend Trading Suppliers and Manufacturers of Iodine 125 (cas 17144-19-3). Pls Click Website Link as below: cas 17144-19-3 suppliers

Prev:Synthesis of benzothiazoles from 2-aminobenzenethiols in the presence of a reusable polythiazolium precatalyst under atmospheric pressure of carbon dioxide
Next:Brief reportIodine-125 seeds in prostatic transurethral resection: Differential diagnosis with schistosome eggsPresencia de I-125 semillas en material de resección transuretral. Diagnóstico diferencial con huevos de esquistosoma)